Intracerebral Hemorrhage Clinical Trial
Official title:
Clinical Outcomes Following Parafascicular Surgical Evaluation of Intracerebral Hemorrhage: A Pilot Study
This pilot study will examine the safety and the clinical outcomes after minimally invasive
surgery (using a parafascicular technique guided by diffusion-tensor imaging) for
intracerebral hemorrhage in patients selected according to evidence-based criteria. The
investigators will compare 30 day and 90 day outcomes of patients who have surgery to that
predicted by previously reported models for recovery after ICH, and will also describe any
surgical complications related to the procedure.
The investigators hypothesize that this technique will have the same mortality rate and
function outcome, if not better, when compared to the outcomes predicted by previous models.
1.1 Intracerebral hemorrhage (ICH) morbidity, mortality, and functional outcomes. ICH is the
most severe form of stroke: 30-day mortality is 40%, and 80% of survivors are physically
disabled. Baseline hematoma volume and expansion are the most important determinants of
outcome and are often therapeutic targets for trials. To date, there is no accepted medical
therapy for ICH, particularly in supratentorial hematomas. Attempts to mitigate neuronal
injury with treatments such as aggressive blood pressure lowering, hemostatic agents,
reversal of anticoagulation, and surgical evacuation have been unsuccessful. We need an
innovative approach to treat this lethal and disabling disease.
1.2 ICH surgery as a therapeutic approach. Mechanical and toxic effects of an accumulating
intracerebral hematoma play an important pathophysiological role in ICH related brain
injury. However, randomized controlled trials of hematoma evacuation have yielded
inconsistent results. The largest randomized controlled trial of surgery for ICH failed to
show a clinical benefit, possibly due to differences in surgical protocols, a 25% cross-over
rate from medical to surgical arms, and substantial delays in onset-to-surgery times (median
3 days). This trial also raised the possibility that collateral injury to normal tissue
during surgery can adversely affect outcome, as patients who appeared to benefit most were
those with superficial and easily accessible hematomas. A subsequent meta-analysis indicated
surgery may be beneficial for acute ICH with careful patient selection and short
onset-to-surgery times. But at present, the surgical evacuation of ICH remains an unproven
therapy.
1.3 Minimally invasive surgery for ICH. Traditionally, two of the strongest influences on
treatment selection have been hematoma depth and dominance of the hemisphere involved, with
a non-operative approach favoured for deep and dominant hematomas. In conventional clot
evacuation, brain retraction is often required to maintain access to the lesion. Brain
contusion and tissue injury is estimated to occur in 5-10% of cases after retraction, and
can result in clinical deficits. Procedure related damage to the subcortical white matter
has also been suggested to contribute to neurocognitive and affective changes after ICH
evacuation. Minimally invasive surgery (MIS) offers potential advantages over conventional
craniotomy, and several groups have developed and examined such techniques. Again, results
have been conflicting and improved functional outcome has not been consistently
demonstrated. MIS techniques specifically designed to avoid eloquent cortex and subcortical
tracts during hematoma evacuation present a new and exciting paradigm for ICH therapy
1.4 Diffusion tensor imaging (DTI) and parafascicular surgical evacuation of ICH. Cerebral
white matter is organized into well-defined fascicles and tracts which allow for neuronal
communication between different functional regions of the cerebral cortex. These fascicles
can be observed and mapped with (DTI), an MRI sequence allowing noninvasive visualization of
the microstructural organization of white matter tracts in the brain. Disruption of these
fascicles interrupts neural transmission between these regions, resulting in neurological
deficits. Techniques designed to avoid fascicular injury have been proposed as a method to
avoid damage associated with ICH surgery. Parafascicular surgery is a minimally-invasive
technique that, combined with DTI, allows for an atraumatic radial corridor to remove
subcortical lesions. This map allows the neurosurgeon to visualize the white matter tracts
surrounding the hematoma and to plan the most appropriate and least disruptive surgical
tract leading to the hematoma. After obtaining DTI data to create a precise trajectory, the
surgeon uses a modified intra-operative computer navigation system to implement a trajectory
plan, and introduce a 13 mm circular integrated port under the visualization of an exoscope
optics platform. The port has a low coefficient of friction, allowing the surgeon to
atraumatically navigate between the fascicles and focally resect the hemorrhage. The
combination of these surgical technologies has demonstrated favorable results in excision of
brain masses, and has recently been used for evacuation of intracerebral hematomas.
Parafascicular surgery with DTI navigation can avoid fascicular damage and collateral injury
during ICH evacuation.
1.5 Predictive models for ICH outcome. Several clinical scores have been validated and used
to predict mortality and functional outcome after ICH, and have been shown to accurately
reflect clinical outcomes, including mortality and functional status. Two of these scores
include the modified ICH score and the Essen ICH score. The modified ICH score uses several
clinical variables: patient age, presenting National Institutes of Health Stroke Scale
(NIHSS) score, hematoma volume and location and presence of intraventricular blood to
provide a numerical score that predicts the chances of mortality and of poor functional
outcome (defined as ≥2 on the modified Rankin Scale (mRS) at 30 days from presentation.
Higher scores are associated with a higher likelihood of poor outcome; scores of 3 are
associated with a 70% likelihood of poor outcome, while a score of 5 was associated with
mortality rates of 100%. The Essen ICH score was developed to determine the likelihood of
functional independence at 100 days from onset. It uses patient age, ICH severity (as
measured by NIHSS) and level of consciousness to determine the odds of independent function,
measured as a score of 95 or higher on the Barthel index. Patients with low scores (<4) had
a 0% chance of achieving functional independence, while 80% of patients with scores >11 were
able to live independently at 90 days. Predictive scores have been used in ischemic stroke
studies to predict mortality and clinical outcomes. Comparison of outcomes in validated
prediction scores is a means to gauge safety and feasibility of intervention.
Hypotheses
This pilot study will evaluate the safety and the clinical outcomes following parafascicular
evacuation of ICH in patients selected according to evidence-based criteria.
2.1 Primary objectives: To compare the 30-day and 90-day functional outcomes of patients
undergoing parafascicular ICH-evacuation surgery as compared to predicted outcomes using
validated ICH prediction scores (the modified ICH score and the Essen ICH score).
2.2 Secondary objectives: To describe and quantify postoperative complications following
parafascicular ICH evacuation.
2.3 Hypotheses: We hypothesize that the parafascicular technique will result in equal or
reduced mortality, and equal or improved functional outcomes, as compared to ICH predictive
scores.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05089331 -
ROSE-Longitudinal Assessment With Neuroimaging
|
||
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Active, not recruiting |
NCT04522102 -
Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral haemorrhaGe (ASPIRING)-Pilot Phase
|
Phase 3 | |
Terminated |
NCT04178746 -
PRONTO: Artemis in the Removal of Intraventricular Hemorrhage in the Hyper-Acute Phase
|
||
Not yet recruiting |
NCT03956485 -
Multicentre Registry of Patients With Spontaneous Acute Intracerebral Hemorrhage in Catalonia (HIC-CAT).
|
||
Enrolling by invitation |
NCT02920645 -
Multicenter Validation of the AVICH Score
|
N/A | |
Recruiting |
NCT02625948 -
Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign
|
Phase 2 | |
Completed |
NCT02478177 -
Addressing Real-world Anticoagulant Management Issues in Stroke
|
||
Completed |
NCT01971359 -
Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study
|
N/A | |
Terminated |
NCT00990509 -
Albumin for Intracerebral Hemorrhage Intervention
|
Phase 2 | |
Completed |
NCT01261091 -
Early Tracheostomy in Ventilated Stroke Patients
|
N/A | |
Completed |
NCT00716079 -
The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial
|
N/A | |
Recruiting |
NCT00222625 -
rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
|
Phase 2 | |
Recruiting |
NCT05095857 -
The Anesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury
|
Phase 4 | |
Recruiting |
NCT04548596 -
NOninVasive Intracranial prEssure From Transcranial doppLer Ultrasound Development of a Comprehensive Database of Multimodality Monitoring Signals for Brain-Injured Patients
|
||
Not yet recruiting |
NCT06429332 -
International Care Bundle Evaluation in Cerebral Hemorrhage Research
|
Phase 4 | |
Recruiting |
NCT05492474 -
Cranial Ultrasound for Prehospital ICH Diagnosis
|
N/A | |
Not yet recruiting |
NCT05502874 -
Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage
|
||
Recruiting |
NCT04604587 -
MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA
|
Phase 3 | |
Recruiting |
NCT05504941 -
Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage
|
N/A |